Europe Pharma News

Spain Explores Italy’s HTA Model to Advance EU HTA Regulation Implementation | iPharmaCenter

Badari Andukuri

7 days ago

Germany Advances Pharmacy Reform with ApoVWG Law to Strengthen Rural Access and Healthcare Services

Badari Andukuri

May 25

Europe’s Pharmaceutical Strategy in a Changing Global Order: Germany and France Push for Resilience and Competitiveness | iPharmaCenter

Badari Andukuri

May 22

New Hope for GVHD Patients as Rezurock Wins EU Approval | iPharmaCenter

Badari Andukuri

Apr 2

Amgen’s Uplizna wins European Commission approval for generalized myasthenia gravis | iPharmaCenter

ipharmaservices

Feb 17

GSK’s ultra‑long‑acting IL‑5 biologic Exdensur wins EU approval for severe asthma and CRSwNP | iPharmaCenter

ipharmaservices

Feb 17

GSK’s RSV Vaccine, Arexvy is now approved for all adults in Europe | iPharmaCenter

ipharmaservices

Feb 1

EMA Begins Review of Trastuzumab Deruxtecan Plus Pertuzumab as First-Line Therapy for HER2 Positive Metastatic Breast Cancer | iPharmaCenter

Badari Andukuri

Jan 20

Germany’s Federal Ministry of Health (BMG) initiated two research funding projects to strengthen women's health | iPharmaCenter

Badari Andukuri

Jan 17

European Commission grants approval to Sanofi's Wayrilz for refractory immune thrombocytopenia | iPharmaCenter

ipharmaservices

Dec 29, 2025

Johnson & Johnson Secures European Commission Approval for IMAAVY (Nipocalimab) to Treat Generalised Myasthenia Gravis

Badari Andukuri

Dec 5, 2025

US–Swiss Tariff Cap Impact on Pharma: How the New US–Swiss Tariff Cap Shapes Pharma and Health Security

ipharmaservices

Dec 2, 2025

EU clears Dupixent as first targeted CSU therapy in over a decade | iPharmaCenter

ipharmaservices

Nov 29, 2025

BMS' Breyanzi CAR-T Therapy Approved for Treating Mantle Cell Lymphoma | iPharmaCenter

ipharmaservices

Nov 25, 2025

European Drug Approvals | CHMP Positive Opinions | January 2025 | iPharmaCenter

ipharmaservices

Feb 3, 2025

Rybrevant plus Lazcluze approved in Europe for EGFR-NSCLC; showed improvement over Tagrisso | iPharmaCenter

ipharmaservices

Jan 2, 2025

Novartis’ Kisqali Gains European Commission Approval for Broader Use in Early Breast Cancer Patients at High Risk of Recurrence | iPharmaCenter

ipharmaservices

Dec 1, 2024

EMA Drug Approvals 2024 | CHMP Positive Opinion | October 2024 | iPharmaCenter

ipharmaservices

Oct 19, 2024

European Commission Greenlights Keytruda and Padcev Combo as First-Line Treatment for Advanced Urothelial Carcinoma | iPharmaCenter

ipharmaservices

Sep 3, 2024

European Commission Expands Approval for GSK's Arexvy, the First RSV Vaccine for Adults Aged 50-59 at Increased Risk | iPharmaCenter

ipharmaservices

Sep 1, 2024

iPharmaCenter

ipharmacenter Consulting services

Spain Explores Italy’s HTA Model to Advance EU HTA Regulation Implementation | iPharmaCenter

Germany Advances Pharmacy Reform with ApoVWG Law to Strengthen Rural Access and Healthcare Services

Europe’s Pharmaceutical Strategy in a Changing Global Order: Germany and France Push for Resilience and Competitiveness | iPharmaCenter

New Hope for GVHD Patients as Rezurock Wins EU Approval | iPharmaCenter

Amgen’s Uplizna wins European Commission approval for generalized myasthenia gravis | iPharmaCenter

GSK’s ultra‑long‑acting IL‑5 biologic Exdensur wins EU approval for severe asthma and CRSwNP | iPharmaCenter

GSK’s RSV Vaccine, Arexvy is now approved for all adults in Europe | iPharmaCenter

EMA Begins Review of Trastuzumab Deruxtecan Plus Pertuzumab as First-Line Therapy for HER2 Positive Metastatic Breast Cancer | iPharmaCenter

Germany’s Federal Ministry of Health (BMG) initiated two research funding projects to strengthen women's health | iPharmaCenter

European Commission grants approval to Sanofi's Wayrilz for refractory immune thrombocytopenia | iPharmaCenter

Johnson & Johnson Secures European Commission Approval for IMAAVY (Nipocalimab) to Treat Generalised Myasthenia Gravis

US–Swiss Tariff Cap Impact on Pharma: How the New US–Swiss Tariff Cap Shapes Pharma and Health Security

EU clears Dupixent as first targeted CSU therapy in over a decade | iPharmaCenter

BMS' Breyanzi CAR-T Therapy Approved for Treating Mantle Cell Lymphoma | iPharmaCenter

European Drug Approvals | CHMP Positive Opinions | January 2025 | iPharmaCenter

Rybrevant plus Lazcluze approved in Europe for EGFR-NSCLC; showed improvement over Tagrisso | iPharmaCenter

Novartis’ Kisqali Gains European Commission Approval for Broader Use in Early Breast Cancer Patients at High Risk of Recurrence | iPharmaCenter

EMA Drug Approvals 2024 | CHMP Positive Opinion | October 2024 | iPharmaCenter

European Commission Greenlights Keytruda and Padcev Combo as First-Line Treatment for Advanced Urothelial Carcinoma | iPharmaCenter

European Commission Expands Approval for GSK's Arexvy, the First RSV Vaccine for Adults Aged 50-59 at Increased Risk | iPharmaCenter

Join our mailing list